FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082938770> ?p ?o ?g. }

• W2082938770 endingPage "8" @default.
• W2082938770 startingPage "1" @default.
• W2082938770 abstract "Angiotensin-converting enzyme (ACE) inhibitors appear to possess unique cardioprotective benefits, even when used in patients without high blood pressure or left ventricular dysfunction (the traditional indications for ACE inhibitor therapy). The ACE inhibitors improve endothelial function and regress both left ventricular hypertrophy and arterial mass better than other antihypertensive agents that lower blood pressure equally as well. These agents promote collateral vessel development and improve prognosis in patients who have had a coronary revascularization procedure (i.e., percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery). Insulin resistance, present not only in type 2 diabetes but also commonly in patients with hypertension or coronary artery disease, or both, sensitizes the vasculature to the trophic effects of angiotensin II and aldosterone. This may partly explain the improvement in prognosis noted when patients who have atherosclerosis or diabetes are treated with an ACE inhibitor. Therapy with ACE inhibitors has also been shown, in two large, randomized trials, to reduce the incidence of new-onset type 2 diabetes through largely unknown mechanisms. The ACE inhibitors are safe, well tolerated and affordable medications. The data suggest that most people with atherosclerosis should be considered candidates for ACE inhibitor therapy, unless they are intolerant to the medication, or have systolic blood pressures consistently <100 mm Hg. Patients who show evidence of insulin resistance (with or without overt type 2 diabetes) should also be considered as candidates for prophylactic ACE inhibitor therapy. Although angiotensin receptor blockers should not be considered equivalent to ACE inhibitors for this indication, they may be a reasonable alternative for patients intolerant of ACE inhibitors." @default.
• W2082938770 created "2016-06-24" @default.
• W2082938770 creator A5004207164 @default.
• W2082938770 creator A5008644032 @default.
• W2082938770 creator A5024111381 @default.
• W2082938770 creator A5045093307 @default.
• W2082938770 creator A5059582018 @default.
• W2082938770 date "2001-01-01" @default.
• W2082938770 modified "2023-09-27" @default.
• W2082938770 title "Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease?" @default.
• W2082938770 cites W160626518 @default.
• W2082938770 cites W180946569 @default.
• W2082938770 cites W1963684082 @default.
• W2082938770 cites W1970813045 @default.
• W2082938770 cites W1975831146 @default.
• W2082938770 cites W1984992817 @default.
• W2082938770 cites W1986836843 @default.
• W2082938770 cites W1987413260 @default.
• W2082938770 cites W1988215184 @default.
• W2082938770 cites W1990978845 @default.
• W2082938770 cites W1993378083 @default.
• W2082938770 cites W1998988712 @default.
• W2082938770 cites W2000293113 @default.
• W2082938770 cites W2001483085 @default.
• W2082938770 cites W2008372707 @default.
• W2082938770 cites W2028710327 @default.
• W2082938770 cites W2034179367 @default.
• W2082938770 cites W2041037406 @default.
• W2082938770 cites W2044045435 @default.
• W2082938770 cites W2050134576 @default.
• W2082938770 cites W2051294952 @default.
• W2082938770 cites W2051837586 @default.
• W2082938770 cites W2054657176 @default.
• W2082938770 cites W2063732928 @default.
• W2082938770 cites W2064099037 @default.
• W2082938770 cites W2074793189 @default.
• W2082938770 cites W2090401517 @default.
• W2082938770 cites W2091301735 @default.
• W2082938770 cites W2092938685 @default.
• W2082938770 cites W2096583106 @default.
• W2082938770 cites W2102979143 @default.
• W2082938770 cites W2103418109 @default.
• W2082938770 cites W2129711762 @default.
• W2082938770 cites W2134461609 @default.
• W2082938770 cites W2137408480 @default.
• W2082938770 cites W2138119952 @default.
• W2082938770 cites W2148231236 @default.
• W2082938770 cites W2151139437 @default.
• W2082938770 cites W2160420760 @default.
• W2082938770 cites W2169776281 @default.
• W2082938770 cites W2170388163 @default.
• W2082938770 cites W2312999996 @default.
• W2082938770 cites W2334899541 @default.
• W2082938770 cites W2615684303 @default.
• W2082938770 cites W3022929210 @default.
• W2082938770 cites W4239943088 @default.
• W2082938770 cites W4252842373 @default.
• W2082938770 cites W4302766818 @default.
• W2082938770 cites W4376848716 @default.
• W2082938770 cites W94380503 @default.
• W2082938770 doi "https://doi.org/10.1016/s0735-1097(00)01044-5" @default.
• W2082938770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11153722" @default.
• W2082938770 hasPublicationYear "2001" @default.
• W2082938770 type Work @default.
• W2082938770 sameAs 2082938770 @default.
• W2082938770 citedByCount "102" @default.
• W2082938770 countsByYear W20829387702014 @default.
• W2082938770 countsByYear W20829387702015 @default.
• W2082938770 countsByYear W20829387702016 @default.
• W2082938770 countsByYear W20829387702017 @default.
• W2082938770 countsByYear W20829387702018 @default.
• W2082938770 countsByYear W20829387702020 @default.
• W2082938770 countsByYear W20829387702021 @default.
• W2082938770 countsByYear W20829387702023 @default.
• W2082938770 crossrefType "journal-article" @default.
• W2082938770 hasAuthorship W2082938770A5004207164 @default.
• W2082938770 hasAuthorship W2082938770A5008644032 @default.
• W2082938770 hasAuthorship W2082938770A5024111381 @default.
• W2082938770 hasAuthorship W2082938770A5045093307 @default.
• W2082938770 hasAuthorship W2082938770A5059582018 @default.
• W2082938770 hasConcept C126322002 @default.
• W2082938770 hasConcept C134018914 @default.
• W2082938770 hasConcept C164705383 @default.
• W2082938770 hasConcept C27016395 @default.
• W2082938770 hasConcept C2777180221 @default.
• W2082938770 hasConcept C2777391703 @default.
• W2082938770 hasConcept C2778213512 @default.
• W2082938770 hasConcept C2779306644 @default.
• W2082938770 hasConcept C2779611605 @default.
• W2082938770 hasConcept C555293320 @default.
• W2082938770 hasConcept C71924100 @default.
• W2082938770 hasConcept C84393581 @default.
• W2082938770 hasConceptScore W2082938770C126322002 @default.
• W2082938770 hasConceptScore W2082938770C134018914 @default.
• W2082938770 hasConceptScore W2082938770C164705383 @default.
• W2082938770 hasConceptScore W2082938770C27016395 @default.
• W2082938770 hasConceptScore W2082938770C2777180221 @default.
• W2082938770 hasConceptScore W2082938770C2777391703 @default.

• next